Australian and New Zealand Anaesthetic Allergy Group Perioperative Anaphylaxis Investigation Guidelines

Anaesthesia and Intensive Care

Volumn 45, Issue 5, 2017, Pages 543-555

  Scolaro, R J ^a   Crilly, H M ^b   Maycock, E J ^c   McAleer, P T ^d   Nicholls, K A ^e   Rose, M A ^f   The, R I H ^g  

^a SUNSHINE COAST UNIVERSITY HOSPITAL   (Australia)

^b The Tweed Hospital   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

anaphylaxis; drug hypersensitivity; intradermal tests; neuromuscular blocking agents; skin tests

Indexed keywords

ALLERGEN; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; CHLORHEXIDINE; CORTICOSTEROID; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; LOCAL ANESTHETIC AGENT; MONTELUKAST; NEUROLEPTIC AGENT; NEUROMUSCULAR BLOCKING AGENT; TRYPTASE; ANESTHETIC AGENT;

ALLERGIC REACTION; ALLERGY TEST; ANAPHYLAXIS; ARTICLE; AUSTRALIA; BACK; BASOPHIL ACTIVATION TEST; CONSENSUS; CONTROL STRATEGY; DILUTION; DRUG HYPERSENSITIVITY; DRUG STABILITY; FOREARM; GOLD STANDARD; HUMAN; IN VITRO STUDY; INFORMED CONSENT; INTRACUTANEOUS TEST; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORBIDITY; NEW ZEALAND; PERIOPERATIVE PERIOD; PHYSICIAN; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRICK TEST; PROCEDURES; SCREENING; SKIN IRRITATION; SKIN TEST;

ANAPHYLAXIS; ANESTHETICS; AUSTRALIA; DRUG HYPERSENSITIVITY; HUMANS; NEW ZEALAND; PERIOPERATIVE PERIOD; SKIN TESTS;

EID: 85045195096     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057X1704500504     Document Type: Article

References (92)

1. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson N.F., Jr., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 2006; 47: 373–380.
2. Australasian Society of Clinical Immunology and Allergy. Skin prick testing for the diagnosis of allergic disease: A manual for practitioners. In: Smith W, ed. http://www.allergy.org.au, 2013.
3. Mertes P.M., Malinovsky J.M., Jouffroy L., Aberer W., Terreehorst I., Brockow K., Demoly P., Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 21: 442–453.
4. Brockow K., Romano A., Blanca M., Ring J., Pichler W., Demoly P., General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45–51.
5. Fisher M.M., The diagnosis of acute anaphylactoid reactions to anaesthetic drugs. Anaesth Intensive Care 1981; 9: 235–241.
6. Fisher M., Intradermal testing after anaphylactoid reaction to anaesthetic drugs: practical aspects of performance and interpretation. Anaesth Intensive Care 1984; 12: 115–120.
7. Harper N.J.N., Dixon T., Dugue P., Edgar D.M., Fay A., Gooi H.C., et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009; 64: 199–211.
8. Mertes P.M., Laxenaire M.C., Lienhart A., Aberer W., Ring J., Pichler W.J., Demoly P., Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 2005; 15: 91–101.
9. Rose M., Fisher M., Anaphylaxis and anaesthesia. What can we do better? Australasian Anaesthesia 2009: 115–121.
10. Fisher M.M., The preoperative detection of risk of anaphylaxis during anaesthesia. Anaesth Intensive Care 2007; 35: 899–902.
11. Mirakian R., Ewan P.W., Durham S.R., Youlten L.J.F., Dugue P., Friedmann P.S., et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2009; 39: 43–61.
12. Barbaud A., Goncalo M., Bruynzeel D., Bircher A., Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321–328.
13. Middleton's Allergy: Principles and Practice. Phildelphia: Elsevier's Health Sciences 2013.
14. Pipkorn U., Hammarlund A., Enerback L., Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen-induced weal-and-flare response and a reduction in skin mast cell numbers and histamine content. Clin Exp Allergy 1989; 19: 19–25.
15. Hill SL, 3rd, Krouse J.H., The effects of montelukast on intradermal wheal and flare. Otolaryngol Head Neck Surg 2003; 129: 199–203.
16. Kupczyk M., Kuprys I., Gorski P., Kuna P., The effect of montelukast (10mg daily) and loratadine (10mg daily) on wheal, flare and itching reactions in skin prick tests. Pulm Pharmacol Ther 2007; 20: 85–89.
17. Des Roches A., Paradis L., Bougeard Y.H., Godard P., Bousquet J., Chanez P., Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. J Allergy Clin Immunol 1996; 98: 522–527.
18. Simons F.E.R., Ardusso L.R.F., Bilo M.B., Cardona V., Ebisawa M., El-Gamal Y.M., et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014; 7: 9.
19. Muraro A., Roberts G., Worm M., Bilo M.B., Brockow K., Fernandez Rivas M., et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69: 1026–1045.
20. Australian Prescriber. Anaphylaxis: Emergency Management for Health Professionals. In: Professionals AEMfH, ed. Australian Prescriber 2011.
21. Liccardi G., D'Amato G., Canonica G.W., Salzillo A., Piccolo A., Passalacqua G., Systemic reactions from skin testing: literature review. J Investig Allergol Clin Immunol 2006; 16: 75–78.
22. Soetens F., Rose M., Fisher M., Timing of skin testing after a suspected anaphylactic reaction during anaesthesia. Acta Anaesthesiol Scand 2012; 56: 1042–1046.
23. Schulberg E.M., Webb A.R., Kolawole H., Early skin and challenge testing after rocuronium anaphylaxis. Anaesth Intensive Care 2016; 44: 425–427.
24. Deidun D., Australian Injectable Drugs Handbook 2011.
25. Nelson H.S., Knoetzer J., Bucher B., Effect of distance between sites and region of the body on results of skin prick tests. J Allergy Clin Immunol 1996; 97: 596–601.
26. Bernstein I.L., Li J.T., Bernstein D.I., Hamilton R., Spector S.L., Tan R., et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008; 100: S1–S148.
27. Werther R.L., Choo S., Lee K.J., Poole D., Allen K.J., Tang M.L.K., Variability in skin prick test results performed by multiple operators depends on the device used. World Allergy Organ J 2012; 5: 200–204.
28. Masse M.S., Granger Vallee A., Chiriac A., Dhivert-Donnadieu H., Bousquet-Rouanet L., Bousquet P-J, Demoly P., Comparison of five techniques of skin prick tests used routinely in Europe. Allergy 2011; 66: 1415–1419.
29. Berg C.M., Heier T., Wilhelmsen V., Florvaag E., Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique. Acta Anaesthesiol Scand 2003; 47: 576–582.
30. Ebo D.G., Fisher M.M., Hagendorens M.M., Bridts C.H., Stevens W.J., Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007; 62: 471–487.
31. Ewan P.W., Dugue P., Mirakian R., Dixon T.A., Harper J.N., Nasser S.M., BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 2010; 40: 15–31.
32. Kaewruttanapattama F., Chokboonpium J., Thammahong A., Klaewsongkram J., A comparison between morphine and histamine as a positive control agent for intradermal skin testing: an evidence-based study. J Investig Allergol Clin Immunol 2010; 20: 626–627.
33. Torres M.J., Blanca M., Fernandez J., Romano A., Weck A., Aberer W., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58: 961–972.
34. Torres M.J., Romano A., Mayorga C., Moya M.C., Guzman A.E., Reche M., et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001; 56: 850–856.
35. Empedrad R., Darter A.L., Earl H.S., Gruchalla R.S., Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003; 112: 629–630.
36. Aberer W., Kranke B., Provocation tests in drug hypersensitivity. Immunol Allergy Clin North Am 2009; 29: 567–584.
37. Sadleir P.H.M., Clarke R.C., Bunning D.L., Platt P.R., Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth 2013; 110: 981–987.
38. Rose M., Fisher M., Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001; 86: 678–682.
39. Mertes P.M., Laxenaire M-C, Alla F., Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 2003; 99: 536–545.
40. Fraser B.A., Smart J.A., Anaphylaxis to cisatracurium following negative skin testing. Anaesth Intensive Care 2005; 33: 816–819.
41. Fisher M.M., Merefield D., Baldo B., Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia. Br J Anaesth 1999; 82: 770–773.
42. Huggan P., Mills G., Mansell C., Antimicrobial handbook—Waikato District Health Board, 2014.
43. Barnett J., Surgical Antimicrobial Prophylaxis Intervention Guidelines: Hip and Knee Arthroplasties. Surgical Site Infection Improvement Programme. Health Quality and Safety Commission New Zealand 2013.
44. Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 14 ed. Melbourne 2010.
45. Hepner D.L., Castells M.C., Anaphylaxis during the perioperative period. Anesth Analg 2003; 97: 1381–1395.
46. Mertes P.M., Alla F., Trechot P., Auroy Y., Jougla E., Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011; 128: 366–373.
47. Brockow K., Garvey L.H., Aberer W., Atanaskovic-Markovic M., Barbaud A., Bilo M.B., et al. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013; 68: 702–712.
48. Pichichero M.E., Zagursky R., Penicillin and cephalosporin allergy. Ann Allergy Asthma Immunol 2014; 112: 404–412.
49. Pichichero M.E., A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005; 115: 1048–1057.
50. Torres M.J., Blanca M., The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am 2010; 94: 805–820, xii.
51. Yoon S-Y, Park S.Y., Kim S., Lee T., Lee Y.S., Kwon H-S, et al. Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge. Allergy 2013; 68: 938–944.
52. Fisher M.M., Bowey C.J., Alleged allergy to local anaesthetics. Anaesth Intensive Care 1997; 25: 611–614.
53. Berkun Y., Ben-Zvi A., Levy Y., Galili D., Shalit M., Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Ann Allergy Asthma Immunol 2003; 91: 342–345.
54. Bhole M.V., Manson A.L., Seneviratne S.L., Misbah S.A., IgE-mediated allergy to local anaesthetics: separating fact from perception: a UK perspective. Br J Anaesth 2012; 108: 903–911.
55. Thyssen J.P., Menne T., Elberling J., Plaschke P., Johansen J.D., Hypersensitivity to local anaesthetics—update and proposal of evaluation algorithm. Contact Dermatitis 2008; 59: 69–78.
56. Krautheim A.B., Jermann T.H.M., Bircher A.J., Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis 2004; 50: 113–116.
57. Mushtaq U., Tan A., Tan Ju A., Smith W.B., Acute allergic reaction after intravenous saline injection: an unusual presentation of chlorhexidine allergy. Med J Aust 2014; 200: 599–600.
58. Garvey L.H., Roed-Petersen J., Husum B., Anaphylactic reactions in anaesthetised patients—four cases of chlorhexidine allergy. Acta Anaesthesiol Scand 2001; 45: 1290–1294.
59. Calogiuri G.F., Di Leo E., Trautmann A., Nettis E., Ferrannini A., Vacca A., Chlorhexidine hypersensitivity: a critical and updated review. J Allergy Ther 2013; 4: 141.
60. Khoo A., Oziemski P., Chlorhexidine impregnated central venous catheter inducing an anaphylatic shock in the intensive care unit. Heart Lung Circ 2011; 20: 669–670.
61. Dewachter P., Mouton-Faivre C., Emala C.W., Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology 2009; 111: 1141–1150.
62. Hagau N., Bologa R.O., Indrei C.L., Longrois D., Dirzu D.S., Gherman-Ionica N., Maximum non-reactive concentration of midazolam and ketamine for skin testing study in non-allergic healthy volunteers. Anaesth Intensive Care 2010; 38: 513–518.
63. Iriarte Sotes P., Lopez Abad R., Gracia Bara M.T., Castro Murga M., Sesma Sanchez P., Codeine-induced generalized dermatitis and tolerance to other opioids. J Investig Allergol Clin Immunol 2010; 20: 89–90.
64. Galindo P.A., Borja J., Mur P., Feo F., Gomez E., Garcia R., Anaphylaxis to paracetamol. Allergol Immunopathol (Madr) 1998; 26: 199–200.
65. Mertes P.M., Moneret-Vautrin D.A., Leynadier F., Laxenaire M-C, Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers. Anesthesiology 2007; 107: 245–252.
66. Levy J.H., Gottge M., Szlam F., Zaffer R., McCall C., Weal and flare responses to intradermal rocuronium and cisatracurium in humans. Br J Anaesth 2000; 85: 844–849.
67. Sadleir P.H.M., Russell T., Clarke R.C., Maycock E., Platt P.R., Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Anaesth Intensive Care 2014; 42: 93–96.
68. Seed M.J., Ewan P.W., Anaphylaxis caused by neostigmine. Anaesthesia 2000; 55: 574–575.
69. Fisher M.M., Bowey C.J., Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth 1997; 79: 59–63.
70. Fernando S.L., Broadfoot A.J., Ondansetron anaphylaxis: a case report and protocol for skin testing. Br J Anaesth 2009; 102: 285–286.
71. Bousquet P.J., Co-Minh H-B, Demoly P., Isolated urticaria to ondansetron and successful treatment with granisetron. Allergy 2005; 60: 543–544.
72. Le Pabic F., Sainte-Laudy J., Blanchard N., Moneret-Vautrin D.A., First case of anaphylaxis to iodinated povidone. Allergy 2003; 58: 826–827.
73. Anders D., Trautmann A., Allergic anaphylaxis due to subcutaneously injected heparin. Allergy Asthma Clin Immunol 2013; 9: 1.
74. Baldo B.A., Pham N.H., Drugs and other agents used in anaesthesia and surgery. Drug Allergy: Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships. Springer 2013.
75. Imbesi S., Nettis E., Minciullo P.L., Di Leo E., Saija A., Vacca A., Gangemi S., Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions. Pharm World Sci 2010; 32: 416–419.
76. Romano A., Gaeta F., Valluzzi R.L., Alonzi C., Viola M., Bousquet P.J., Diagnosing hypersensitivity reactions to cephalosporins in children. Pediatrics 2008; 122: 521–527.
77. Romano A., Gueant-Rodriguez R-M, Viola M., Amoghly F., Gaeta F., Nicolas J-P, Gueant J-L, Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005; 35: 1234–1242.
78. Testi S., Severino M., Iorno M.L., Capretti S., Ermini G., Macchia D., Campi P., Nonirritating concentration for skin testing with cephalosporins. J Investig Allergol Clin Immunol 2010; 20: 171–172.
79. Christiansen I.S., Kroigaard M., Mosbech H., Skov P.S., Poulsen L.K., Garvey L.H., Clinical and diagnostic features of perioperative hypersensitivity to cefuroxime. Clin Exp Allergy 2015; 45: 807–814.
80. Atanaskovic-Markovic M., Gaeta F., Medjo B., Viola M., Nestorovic B., Romano A., Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins. Allergy 2008; 63: 237–240.
81. Romano A., Viola M., Gueant-Rodriguez R-M, Gaeta F., Valluzzi R., Gueant J-L, Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med 2007; 146: 266–269.
82. Gonzalez I., Lobera T., Blasco A., del Pozo M.D., Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity. J Investig Allergol Clin Immunol 2005; 15: 146–149.
83. Broz P., Harr T., Hecking C., Grize L., Scherer K., Jaeger K.A., Bircher A.J., Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. Allergy 2012; 67: 647–652.
84. Aranda A., Mayorga C., Ariza A., Dona I., Blanca-Lopez N., Canto G., et al. IgE-mediated hypersensitivity reactions to methylprednisolone. Allergy 2010; 65: 1376–1380.
85. Baker A., Empson M., The R., Fitzharris P., Skin testing for immediate hypersensitivity to corticosteroids: a case series and literature review. Clin Exp Allergy 2015; 45: 669–676.
86. Venturini M., Lobera T., del Pozo M.D., Gonzalez I., Blasco A., Immediate hypersensitivity to corticosteroids. J Investig Allergol Clin Immunol 2006; 16: 51–56.
87. Brockow K., Romano A., Aberer W., Bircher A.J., Barbaud A., Bonadonna P., et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy 2009; 64: 234–241.
88. Kalogeromitros D.C., Makris M.P., Aggelides X.S., Spanoudaki N., Gregoriou S.G., Avgerinou G., Rigopoulos D.G., Anaphylaxis to gadobenate dimeglumine (Multihance): a case report. Int Arch Allergy Immunol 2007; 144: 150–154.
89. Lee H.K., Choi E.J., Lee P.B., Nahm F.S., Anaphylactic shock caused by the epidurally-administered hyalurinidase. Korean J Pain 2011; 24: 221–225.
90. Eberhart A.H., Weiler C.R., Erie J.C., Angioedema related to the use of hyaluronidase in cataract surgery. Am J Ophthalmol 2004; 138: 142–143.
91. Dumond P., Franck P., Morisset M., Sainte Laudy J., Kanny G., Moneret-Vautrin D.A., Pre-lethal anaphylaxis to carboxymethylcellulose confirmed by identification of specific IgE–review of the literature. Eur Ann Allergy Clin Immunol 2009; 41: 171–176.
92. Maycock E.J., Russell W.C., Anaphylactoid reaction to Syntocinon. Anaesth Intensive Care 1993; 21: 211–212.